Evidence map›Paper›PMID 41986579›Full record

ArticleCommunications biology2026

Global genomic and molecular epidemiology of carbapenem-resistant Enterobacter hormaechei.

Xiaoqian Long, Xiaohe Hu, Na Liu, Yujie Zhu, Guoping Zhao, Jiangang Ma, Biao Tang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xiaoqian Long *Key Laboratory of Systems Health Science of Zhejiang Province, School of Life Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
Xiaohe Hu *Key Laboratory of Systems Health Science of Zhejiang Province, School of Life Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
Na Liu *Translational Medicine Research Center, Zhengzhou People's Hospital, The Fifth Clinical College of Henan University of Chinese Medicine, Zhengzhou, Henan, China.
Yujie ZhuCenter for Supramolecular Chemistry & Catalysis and Department of Chemistry, College of Science, Shanghai University, Shanghai, China.
Guoping ZhaoKey Laboratory of Systems Health Science of Zhejiang Province, School of Life Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, Zhejiang, China.ORCID http://orcid.org/0000-0002-7621-6620
Jiangang MaXianghu Laboratory, Hangzhou, Zhejiang, China. vetmajg@163.com.ORCID http://orcid.org/0000-0001-9457-4803
Biao TangKey Laboratory of Systems Health Science of Zhejiang Province, School of Life Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, Zhejiang, China. tangbiao@ucas.ac.cn.ORCID http://orcid.org/0000-0002-3605-4022

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbapenem-resistant Enterobacter hormaechei (CR-Eh) represents a critical global health threat, especially when carrying mobile antimicrobial resistance genes (ARGs) like bla

Indexed as

Carbapenem-Resistant EnterobacteriaceaeCarbapenemsEnterobacterEnterobacteriaceae InfectionsGenome, BacterialAnti-Bacterial Agentsbeta-LactamasesGenetic VariationGenomicsHumansMicrobial Sensitivity TestsMolecular EpidemiologyPhylogenyPlasmidsAnti-Bacterial Agentsbeta-LactamasesCarbapenems

Identifiers

PMID41986579
PMCPMC13458537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.